Yi Lü
Impact in
- Pharmaceutical Science top 0.01%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 83
- Drug Solubulity and Delivery Systems 61
- Advancements in Transdermal Drug Delivery 34
-
- RNA Interference and Gene Delivery 16
- Lipid Membrane Structure and Behavior 13
- Co-authors
- Wei Wu (170 shared papers)Jianping Qi (120 shared papers)Haisheng He (48 shared papers)Zhongjian Chen (37 shared papers)Weili Zhao (34 shared papers)Quangang Zhu (27 shared papers)Xiaochun Dong (31 shared papers)Fuqiang Hu (11 shared papers)
- Journals
- International Journal of Pharmaceutics (28 papers)Acta Pharmaceutica Sinica B (14 papers)Drug Discovery Today (10 papers)Chinese Chemical Letters (10 papers)International Journal of Nanomedicine (9 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yi Lü
243 papers receiving 9.8k citations
Yi Lü's Hit Papers
Peers
Comparison fields: 5 of 157
- Pharmaceutical Science 4.4k
- Biomaterials 2.3k
- Molecular Medicine 348
- Pharmacology 406
- Food Science 798
Countries citing papers authored by Yi Lü
This map shows the geographic impact of Yi Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Lü more than expected).
Fields of papers citing papers by Yi Lü
This network shows the impact of papers produced by Yi Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Lü. The network helps show where Yi Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adapting liposomes for oral drug delivery Hit paper breakdown → | 2018 | 510 |
| 2 | Oral delivery of proteins and peptides: Challenges, status quo and future perspectives Hit paper breakdown → | 2021 | 255 |
| 3 | 2009 | 236 | |
| 4 | 2019 | 235 | |
| 5 | 2012 | 198 | |
| 6 | 2013 | 167 | |
| 7 | 2021 | 162 | |
| 8 | 2016 | 162 | |
| 9 | 2013 | 159 | |
| 10 | 2013 | 158 | |
| 11 | 2016 | 155 | |
| 12 | 2012 | 154 | |
| 13 | 2017 | 146 | |
| 14 | 2011 | 131 | |
| 15 | 2022 | 123 | |
| 16 | 2019 | 112 | |
| 17 | 2015 | 110 | |
| 18 | 2009 | 109 | |
| 19 | 2017 | 109 | |
| 20 | 2012 | 107 |
About Yi Lü
Yi Lü is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Organic Chemistry and Materials Chemistry, having authored 251 papers that have together received 10.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (83 papers), Drug Solubulity and Delivery Systems (61 papers), Nanoparticle-Based Drug Delivery (43 papers), Advancements in Transdermal Drug Delivery (34 papers), Surfactants and Colloidal Systems (19 papers), RNA Interference and Gene Delivery (16 papers), Drug Transport and Resistance Mechanisms (14 papers) and Lipid Membrane Structure and Behavior (13 papers). The work is most often cited by research in Pharmaceutical Science (4.4k citations), Biomaterials (2.3k citations), Molecular Medicine (348 citations), Pharmacology (406 citations) and Food Science (798 citations). Yi Lü has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Wei Wu, Jianping Qi, Haisheng He, Zhongjian Chen, Weili Zhao, Quangang Zhu, Xiaochun Dong, Fuqiang Hu, Mengmeng Niu and Yongjiu Lv. Their work appears in journals such as International Journal of Pharmaceutics, Acta Pharmaceutica Sinica B, Drug Discovery Today, Chinese Chemical Letters and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.